Company Management, Scientific and Advisory Boards

Hematology publications

Chajari, M., Lacroix, J., Peny, A.-M., Chesnay, E., Batalla, A., Henry-Amar, M., … Bardet, S. (2002). Gallium-67 scintigraphy in lymphoma: is there a benefit of image fusion with computed tomography? European Journal of Nuclear Medicine and Molecular Imaging, 29(3), 380–387.
Rolland, D., Ribrag, V., Haioun, C., Ghesquieres, H., Jardin, F., Bouabdallah, R., … Thieblemont, C. (2010). Phase II trial and prediction of response of single agent tipifarnib in patients with relapsed/refractory mantle cell lymphoma: a Groupe d’Etude des Lymphomes de l’Adulte trial. Cancer Chemotherapy and Pharmacology, 65(4), 781–790.
Moulin-Romsee, G., Hindié, E., Cuenca, X., Brice, P., Decaudin, D., Bénamor, M., … Moretti, J.-L. (2010). 18F-FDG PET/CT bone/bone marrow findings in Hodgkin’s lymphoma may circumvent the use of bone marrow trephine biopsy at diagnosis staging. European Journal of Nuclear Medicine and Molecular Imaging, 37(6), 1095–1105.
Itti, E., Juweid, M. E., Haioun, C., Yeddes, I., Hamza-Maaloul, F., El Bez, I., … Meignan, M. (2010). Improvement of Early 18F-FDG PET Interpretation in Diffuse Large B-Cell Lymphoma: Importance of the Reference Background. Journal of Nuclear Medicine, 51(12), 1857–1862.
de Bazelaire, C., & de Kerviler, E. (2011). From multislice CT to whole-body biomarker imaging in lymphoma patients. European Radiology, 21(3), 555–558.
Schnell, D., Mayaux, J., de Bazelaire, C., Legoff, J., Feuillet, S., Scieux, C., … Azoulay, É. (2010). Risk factors for pneumonia in immunocompromised patients with influenza. Respiratory Medicine, 104(7), 1050–1056.
Safar, V., Dupuis, J., Itti, E., Jardin, F., Fruchart, C., Bardet, S., … Haioun, C. (2012). Interim [ 18 F]Fluorodeoxyglucose Positron Emission Tomography Scan in Diffuse Large B-Cell Lymphoma Treated With Anthracycline-Based Chemotherapy Plus Rituximab. Journal of Clinical Oncology, 30(2), 184–190.
Leseur, J., Devillers, A., Williaume, D., Le Prisé, E., Fougerou, C., Bouriel, C., … Garin, E. (2011). Tomographie par émission de positons au (18F)-fluorodésoxyglucose dans les cancers du col utérin : évaluation ganglionnaire et valeur pronostique/prédictive des données de la tumeur primitive. Cancer/Radiothérapie, 15(8), 699–708.
Casasnovas, R.-O., Meignan, M., Berriolo-Riedinger, A., Bardet, S., Julian, A., Thieblemont, C., … Morschhauser, F. (2011). SUVmax reduction improves early prognosis value of interim positron emission tomography scans in diffuse large B-cell lymphoma. Blood, 118(1), 37–43.
Sibon, D., Ertault, M., Al Nawakil, C., de Bazelaire, C., Franchi, P., Brière, J., … Brice, P. (2011). Combined ifosfamide, etoposide and oxalipatin chemotherapy, a low-toxicity regimen for first-relapsed or refractory Hodgkin lymphoma after ABVD/EBVP: a prospective monocentre study on 34 patients: IVOx Salvage Regimen for Hodgkin Lymphoma. British Journal of Haematology, 153(2), 191–198.
Romero, M., Brière, J., de Bazelaire, C., Lebœuf, C., Wang, L., Ratajczak, P., … Janin, A. (2011). Aflibercept-mediated early angiogenic changes in aggressive B-cell lymphoma. Cancer Chemotherapy and Pharmacology, 68(5), 1135–1143.
de Kerviler, E., Benet, C., Brière, J., & de Bazelaire, C. (2012). Image-guided needle biopsy for diagnosis and molecular biology in lymphomas. Best Practice & Research Clinical Haematology, 25(1), 29–39.
Bergeron, A., Porcher, R., Sulahian, A., de Bazelaire, C., Chagnon, K., Raffoux, E., … Ribaud, P. (2012). The strategy for the diagnosis of invasive pulmonary aspergillosis should depend on both the underlying condition and the leukocyte count of patients with hematologic malignancies. Blood, 119(8), 1831–1837.
Biggi, A., Gallamini, A., Chauvie, S., Hutchings, M., Kostakoglu, L., Gregianin, M., … Barrington, S. F. (2013). International Validation Study for Interim PET in ABVD-Treated, Advanced-Stage Hodgkin Lymphoma: Interpretation Criteria and Concordance Rate Among Reviewers. Journal of Nuclear Medicine, 54(5), 683–690.
Itti, E., Meignan, M., Berriolo-Riedinger, A., Biggi, A., Cashen, A. F., Véra, P., … Haioun, C. (2013). An international confirmatory study of the prognostic value of early PET/CT in diffuse large B-cell lymphoma: comparison between Deauville criteria and ΔSUVmax. European Journal of Nuclear Medicine and Molecular Imaging, 40(9), 1312–1320.
Gay, J., Lemiale, V., Meignin, V., Bron, C., De Bazelaire, C., Schnell, D., … Azoulay, E. (2013). Diagnostic contribution from pulmonary biopsies in hematology patients with acute respiratory failure from undetermined etiology. Minerva Anestesiologica, 79(8), 853–860.
de Bazelaire, C., Coffin, A., Cohen-Zarade, S., de Margerie-Mellon, C., Scemama, A., Sabatier, F., … de Kerviler, E. (2013). CT-guided biopsies in lung infections in patients with haematological malignancies. Diagnostic and Interventional Imaging, 94(2), 202–215.
Bailly, C., Eugène, T., Couec, M.-L., Strullu, M., Frampas, E., Campion, L., … Bodet-Milin, C. (2014). Prognostic Value and Clinical Impact of 18FDG-PET in the Management of Children with Burkitt Lymphoma after Induction Chemotherapy. Frontiers in Medicine, 1.
D’Anastasi, M., Notohamiprodjo, M., Schmidt, G. P., Dürr, H.-R., Reiser, M. F., & Baur-Melnyk, A. (2014). Tumor Load in Patients With Multiple Myeloma: β 2 -Microglobulin Levels Versus Whole-Body MRI. American Journal of Roentgenology, 203(4), 854–862.
Monjanel, H., Deville, L., Ram-Wolff, C., Venon, M.-D., Franchi, P., Benet, C., … Brice, P. (2014). Brentuximab vedotin in heavily treated Hodgkin and anaplastic large-cell lymphoma, a single centre study on 45 patients. British Journal of Haematology, 166(2), 306–308.
Fleury, I., Amorim, S., Mounier, N., Coiffier, B., Dupuis, J., Tilly, H., … Thieblemont, C. (2015). Management and prognosis of 66 patients with B-cell non-Hodgkin lymphoma presenting with initial spinal cord compression: a French retrospective multicenter study. Leukemia & Lymphoma, 56(7), 2025–2031.
Illidge, T. M., Mayes, S., Pettengell, R., Bates, A. T., Bayne, M., Radford, J. A., … Morschhauser, F. (2014). Fractionated 90 Y-Ibritumomab Tiuxetan Radioimmunotherapy As an Initial Therapy of Follicular Lymphoma: An International Phase II Study in Patients Requiring Treatment According to GELF/BNLI Criteria. Journal of Clinical Oncology, 32(3), 212–218.
Sasanelli, M., Meignan, M., Haioun, C., Berriolo-Riedinger, A., Casasnovas, R.-O., Biggi, A., … Itti, E. (2014). Pretherapy metabolic tumour volume is an independent predictor of outcome in patients with diffuse large B-cell lymphoma. European Journal of Nuclear Medicine and Molecular Imaging, 41(11), 2017–2022.
Schlemmer, F., Chevret, S., Lorillon, G., De Bazelaire, C., Peffault de Latour, R., Meignin, V., … Bergeron, A. (2014). Late-onset noninfectious interstitial lung disease after allogeneic hematopoietic stem cell transplantation. Respiratory Medicine, 108(10), 1525–1533.
Varma, G., Duhamel, G., de Bazelaire, C., & Alsop, D. C. (2015). Magnetization transfer from inhomogeneously broadened lines: A potential marker for myelin: Magnetization Transfer from Inhomogeneously Broadened Lines. Magnetic Resonance in Medicine, 73(2), 614–622.
Bernard, S., Goldwirt, L., Amorim, S., Brice, P., Brière, J., de Kerviler, E., … Thieblemont, C. (2015). Activity of ibrutinib in mantle cell lymphoma patients with central nervous system relapse. Blood, 126(14), 1695–1698.
Battistella, M., Sallé de Chou, C., de Bazelaire, C., Cayuela, J. M., de Kerviler, E., Bagot, M., & Janin, A. (2016). Lymph node image-guided core-needle biopsy for cutaneous T-cell lymphoma staging. British Journal of Dermatology, 175(6), 1397–1400.
Bodet-Milin, C., Kraeber-Bodéré, F., Eugène, T., Guérard, F., Gaschet, J., Bailly, C., … Chevallier, P. (2016). Radioimmunotherapy for Treatment of Acute Leukemia. Seminars in Nuclear Medicine, 46(2), 135–146.
Moreau, P., Attal, M., Caillot, D., Macro, M., Karlin, L., Garderet, L., … Kraeber-Bodere, F. (2017). Prospective Evaluation of Magnetic Resonance Imaging and [ 18 F]Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography at Diagnosis and Before Maintenance Therapy in Symptomatic Patients With Multiple Myeloma Included in the IFM/DFCI 2009 Trial: Results of the IMAJEM Study. Journal of Clinical Oncology, 35(25), 2911–2918.
Bailly, C., Leforestier, R., Jamet, B., Carlier, T., Bourgeois, M., Guérard, F., … Bodet-Milin, C. (2017). PET Imaging for Initial Staging and Therapy Assessment in Multiple Myeloma Patients. International Journal of Molecular Sciences, 18(2), 445.
Zwarthoed, C., El-Galaly, T. C., Canepari, M., Ouvrier, M. J., Viotti, J., Ettaiche, M., … Gallamini, A. (2017). Prognostic Value of Bone Marrow Tracer Uptake Pattern in Baseline PET Scans in Hodgkin Lymphoma: Results from an International Collaborative Study. Journal of Nuclear Medicine, 58(8), 1249–1254.
Kraeber-Bodere, F., Pallardy, A., Maisonneuve, H., Campion, L., Moreau, A., Soubeyran, I., … Soubeyran, P. (2017). Consolidation anti-CD22 fractionated radioimmunotherapy with 90 Y-epratuzumab tetraxetan following R-CHOP in elderly patients with diffuse large B-cell lymphoma: a prospective, single group, phase 2 trial. The Lancet Haematology, 4(1), e35–e45.
Delfau-Larue, M.-H., van der Gucht, A., Dupuis, J., Jais, J.-P., Nel, I., Beldi-Ferchiou, A., … Itti, E. (2018). Total metabolic tumor volume, circulating tumor cells, cell-free DNA: distinct prognostic value in follicular lymphoma. Blood Advances, 2(7), 807–816.
Chantepie, S., Hovhannisyan, N., Guillouet, S., Pelage, J.-P., Ibazizene, M., Bodet-Milin, C., … Barré, L. (2018). 18 F-Fludarabine PET for Lymphoma Imaging: First-in-Humans Study on DLBCL and CLL Patients. Journal of Nuclear Medicine, 59(9), 1380–1385.
Burggraaff, C. N., Cornelisse, A. C., Hoekstra, O. S., Lugtenburg, P. J., De Keizer, B., Arens, A. I. J., … Zijlstra, J. M. (2018). Interobserver Agreement of Interim and End-of-Treatment 18 F-FDG PET/CT in Diffuse Large B-Cell Lymphoma: Impact on Clinical Practice and Trials. Journal of Nuclear Medicine, 59(12), 1831–1836.
Bailly, C., Gouard, S., Lacombe, M., Saëc, P. R.-L., Chalopin, B., Bourgeois, M., … Bodet-Milin, C. (2018). Comparison of Immuno-PET of CD138 and PET imaging with 64CuCl2 and 18F-FDG in a preclinical syngeneic model of multiple myeloma. Oncotarget, 9(10).
Bailly, C., Carlier, T., Jamet, B., Eugene, T., Touzeau, C., Attal, M., … Bodet-Milin, C. (2018). Interim PET Analysis in First-Line Therapy of Multiple Myeloma: Prognostic Value of ΔSUVmax in the FDG-Avid Patients of the IMAJEM Study. Clinical Cancer Research, 24(21), 5219–5224.
Bouard, L., Bodet-Milin, C., Bailly, C., Guillaume, T., Peterlin, P., Garnier, A., … Chevallier, P. (2019). Deauville Scores 4 or 5 Assessed by Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Early Post-Allotransplant Is Highly Predictive of Relapse in Lymphoma Patients. Biology of Blood and Marrow Transplantation, 25(5), 906–911.
Chiche, J., Reverso-Meinietti, J., Mouchotte, A., Rubio-Patiño, C., Mhaidly, R., Villa, E., … Ricci, J.-E. (2019). GAPDH Expression Predicts the Response to R-CHOP, the Tumor Metabolic Status, and the Response of DLBCL Patients to Metabolic Inhibitors. Cell Metabolism, 29(6), 1243-1257.e10.